DIANA BROSIUS: Open Payments
NPI 1407598048 · BEREA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 86 payments from 15 companies in 2025. Trend: 2023 $20 · 2024 $1,219 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 35 | $489 |
| Corium, LLC | 12 | $292 |
| ABBVIE INC. | 17 | $202 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| Sage Therapeutics, LLC | 3 | $62 |
| Alkermes, Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 3 | $47 |
| Dexcom, Inc. | 1 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Insulet Corporation | 1 | $19 |
Products named: CAPLYTA, Azstarys, VRAYLAR, Auvelity, ZURZUVAE, INGREZZA, Dexcom G6 Transmitter, LYBALVI.
Industry payments across KY — which companies pay providers there.
